Blogs

Rare Disease Report: Is Eteplirsen Effective in Non-ambulatory Duchenne Patients?

February 1, 2016

Christine McSherry, founder of the Jett Foundation talks about her son’s experience as a non-ambulatory Duchenne muscular dystrophy patient taking Sarepta’s eteplirsen.

SOURCE | RARE DISEASE REPORT

Stay Connected

Sign up for updates straight to your inbox.

FacebookTwitterInstagramYoutube